Follow
Iain M. Cockburn
Iain M. Cockburn
Questrom School of Business, Boston University
Verified email at bu.edu - Homepage
Title
Cited by
Cited by
Year
Measuring competence? Exploring firm effects in pharmaceutical research
R Henderson, I Cockburn
Strategic management journal 15 (S1), 63-84, 2006
46232006
Scale, scope and spillovers: the determinants of research productivity in drug discovery
R Henderson, I Cockburn
RAND Journal of Economics 27 (1), 32-59, 1996
2068*1996
Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery
IM Cockburn, RM Henderson
The journal of industrial economics 46 (2), 157-182, 1998
19801998
Gone but not forgotten: knowledge flows, labor mobility, and enduring social relationships
A Agrawal, I Cockburn, J McHale
Journal of Economic Geography 6 (5), 571-591, 2006
1088*2006
The economics of reproducibility in preclinical research
LP Freedman, IM Cockburn, TS Simcoe
PLoS biology 13 (6), e1002165, 2015
10852015
Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents
I Cockburn, Z Griliches
The American Economic Review 78 (2), 419-423, 1988
10551988
Untangling the origins of competitive advantage
I Cockburn, R Henderson, S Stern
Strategic Management Journal 21 (10-11), 112-1145, 2000
10532000
The impact of artificial intelligence on innovation
IM Cockburn, R Henderson, S Stern
National bureau of economic research, 2018
8282018
Opportunity costs and entrepreneurial activity
R Amit, E Muller, I Cockburn
Journal of business venturing 10 (2), 95-106, 1995
6081995
Information technology and intangible output: The impact of IT investment on innovation productivity
L Kleis, P Chwelos, RV Ramirez, I Cockburn
Information Systems Research 23 (1), 42-59, 2012
6072012
The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems
A Agrawal, I Cockburn
International journal of industrial organization 21 (9), 1227-1253, 2003
6052003
Characteristics of demand for pharmaceutical products: an examination of four cephalosporins
SF Ellison, I Cockburn, Z Griliches, J Hausman
The RAND journal of Economics, 426-446, 1997
3401997
Are all patent examiners equal? Examiners, patent characteristics, and litigation outcomes
I Cockburn, S Kortum, S Stern
Patents in the knowledge-based economy, 17-53, 2003
334*2003
Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
IM Cockburn, RM Henderson
Journal of health economics 20 (6), 1033-1057, 2001
3342001
New pills for poor people? Empirical evidence after GATT
JO Lanjouw, IM Cockburn
World Development 29 (2), 265-289, 2001
330*2001
Patents and the survival of Internet-related IPOs
S Wagner, I Cockburn
Research Policy 39 (2), 214-228, 2010
290*2010
Racing to invest? The dynamics of competition in ethical drug discovery
I Cockburn, R Henderson
Journal of Economics & Management Strategy 3 (3), 481-519, 1994
2901994
The changing structure of the pharmaceutical industry
IM Cockburn
Health Affairs 23 (1), 10-22, 2004
2882004
Mixed Poisson regression models with covariate dependent rates
P Wang, ML Puterman, I Cockburn, N Le
Biometrics, 381-400, 1996
2851996
Generics and New Goods in Pharmaceutical Price Indexes
Z Griliches, I Cockburn
The American Economic Review 84 (5), 1213-1232, 1994
2761994
The system can't perform the operation now. Try again later.
Articles 1–20